Hopes for a successful chikungunya vaccine rose in recent weeks.
The vaccine development company PaxVax Inc. announced that the FDA has marked their preliminary immunization for fast-track status.
Such a vaccine would be the first of its kind. As the CDC shares, there is currently no vaccination to prevent the infection. Considering there is no medicine to treat chikungunya, this is even more of a problem.